Integral Health Asset Management, LLC Nurix Therapeutics, Inc. Transaction History
Integral Health Asset Management, LLC
- $987 Million
- Q2 2025
A detailed history of Integral Health Asset Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 310,000 shares of NRIX stock, worth $2.81 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
310,000
Previous 275,000
12.73%
Holding current value
$2.81 Million
Previous $3.27 Million
8.05%
% of portfolio
0.36%
Previous 0.38%
Shares
5 transactions
Others Institutions Holding NRIX
# of Institutions
174Shares Held
79.4MCall Options Held
126KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$61.9 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.06MShares$55.1 Million2.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$40.5 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.95MShares$35.9 Million4.19% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$35.2 Million0.45% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $428M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...